Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Nephros (NEPH) Shares Outstanding (Weighted Average) (2016 - 2025)

Nephros has reported Shares Outstanding (Weighted Average) over the past 16 years, most recently at $10.6 million for Q4 2025.

  • Quarterly results put Shares Outstanding (Weighted Average) at $10.6 million for Q4 2025, up 0.83% from a year ago — trailing twelve months through Dec 2025 was $10.6 million (up 0.83% YoY), and the annual figure for FY2025 was $10.6 million, up 0.83%.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $10.6 million at Nephros, roughly flat from $10.6 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for NEPH hit a ceiling of $10.6 million in Q4 2025 and a floor of $9.9 million in Q1 2021.
  • Median Shares Outstanding (Weighted Average) over the past 5 years was $10.3 million (2022), compared with a mean of $10.3 million.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): rose 15.05% in 2021 and later increased 0.31% in 2023.
  • Nephros' Shares Outstanding (Weighted Average) stood at $10.0 million in 2021, then increased by 2.79% to $10.3 million in 2022, then increased by 0.86% to $10.4 million in 2023, then rose by 1.34% to $10.5 million in 2024, then rose by 0.83% to $10.6 million in 2025.
  • The last three reported values for Shares Outstanding (Weighted Average) were $10.6 million (Q4 2025), $10.6 million (Q3 2025), and $10.6 million (Q2 2025) per Business Quant data.